262 related articles for article (PubMed ID: 7619101)
21. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years.
Klein R; Klein BE; Moss SE; Davis MD; DeMets DL
Arch Ophthalmol; 1989 Feb; 107(2):237-43. PubMed ID: 2916977
[TBL] [Abstract][Full Text] [Related]
22. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. A comparison of retinopathy in younger and older onset diabetic persons.
Klein R; Davis MD; Moss SE; Klein BE; DeMets DL
Adv Exp Med Biol; 1985; 189():321-35. PubMed ID: 4036719
[TBL] [Abstract][Full Text] [Related]
23. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more.
Klein R; Klein BE; Moss SE; Davis MD; DeMets DL
Arch Ophthalmol; 1989 Feb; 107(2):244-9. PubMed ID: 2644929
[TBL] [Abstract][Full Text] [Related]
24. Diabetic retinopathy. Assessment of severity and progression.
Klein BE; Davis MD; Segal P; Long JA; Harris WA; Haug GA; Magli YL; Syrjala S
Ophthalmology; 1984 Jan; 91(1):10-7. PubMed ID: 6709313
[TBL] [Abstract][Full Text] [Related]
25. Alcohol consumption and the prevalence of diabetic retinopathy.
Moss SE; Klein R; Klein BE
Ophthalmology; 1992 Jun; 99(6):926-32. PubMed ID: 1630783
[TBL] [Abstract][Full Text] [Related]
26. Retinal vascular geometry and 6 year incidence and progression of diabetic retinopathy.
Cheung CY; Sabanayagam C; Law AK; Kumari N; Ting DS; Tan G; Mitchell P; Cheng CY; Wong TY
Diabetologia; 2017 Sep; 60(9):1770-1781. PubMed ID: 28623387
[TBL] [Abstract][Full Text] [Related]
27. The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy.
Klein R; Lee KE; Gangnon RE; Klein BE
Ophthalmology; 2010 Jan; 117(1):63-70. PubMed ID: 19880184
[TBL] [Abstract][Full Text] [Related]
28. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy.
Klein R; Klein BE; Moss SE; Davis MD; DeMets DL
JAMA; 1988 Nov; 260(19):2864-71. PubMed ID: 3184351
[TBL] [Abstract][Full Text] [Related]
29. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy.
Klein R; Klein BE; Moss SE
Diabetes; 1995 Jul; 44(7):796-801. PubMed ID: 7789648
[TBL] [Abstract][Full Text] [Related]
30. Wisconsin Epidemiologic Study of Diabetic Retinopathy. XII. Relationship of C-peptide and diabetic retinopathy.
Klein R; Moss SE; Klein BE; Davis MD; DeMets DL
Diabetes; 1990 Nov; 39(11):1445-50. PubMed ID: 2121570
[TBL] [Abstract][Full Text] [Related]
31. A population-based study of diabetic retinopathy in insulin-using patients diagnosed before 30 years of age.
Klein R; Klein BE; Moss SE
Diabetes Care; 1985; 8 Suppl 1():71-6. PubMed ID: 4053957
[TBL] [Abstract][Full Text] [Related]
32. The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Cruickshanks KJ; Ritter LL; Klein R; Moss SE
Ophthalmology; 1993 Jun; 100(6):862-7. PubMed ID: 8510898
[TBL] [Abstract][Full Text] [Related]
33. Five-year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project.
McCarty DJ; Fu CL; Harper CA; Taylor HR; McCarty CA
Clin Exp Ophthalmol; 2003 Oct; 31(5):397-402. PubMed ID: 14516426
[TBL] [Abstract][Full Text] [Related]
34. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
[TBL] [Abstract][Full Text] [Related]
35. Physical activity and the risk of progression of retinopathy or the development of proliferative retinopathy.
Cruickshanks KJ; Moss SE; Klein R; Klein BE
Ophthalmology; 1995 Aug; 102(8):1177-82. PubMed ID: 9097744
[TBL] [Abstract][Full Text] [Related]
36. A cohort study of the relationship of diabetic retinopathy to blood pressure.
Klein BE; Klein R; Moss SE; Palta M
Arch Ophthalmol; 1995 May; 113(5):601-6. PubMed ID: 7748130
[TBL] [Abstract][Full Text] [Related]
37. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema.
Klein R; Moss SE; Klein BE; Davis MD; DeMets DL
Ophthalmology; 1989 Oct; 96(10):1501-10. PubMed ID: 2587045
[TBL] [Abstract][Full Text] [Related]
38. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study.
Cikamatana L; Mitchell P; Rochtchina E; Foran S; Wang JJ
Eye (Lond); 2007 Apr; 21(4):465-71. PubMed ID: 17318200
[TBL] [Abstract][Full Text] [Related]
39. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
Kristinsson JK
Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
[TBL] [Abstract][Full Text] [Related]
40. Association of Skin Intrinsic Fluorescence with Retinal Microvascular Complications of Long Term Type 1 Diabetes in the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Klein BEK; Horak KL; Maynard JD; Lee KE; Klein R
Ophthalmic Epidemiol; 2017 Aug; 24(4):211-216. PubMed ID: 28287861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
